SEC Company Response from CASSAVA SCIENCES INC (FLNA) (CIK 0001069530) (FLNA) — Aug 6, 2010
CASSAVA SCIENCES INC (FLNA) (CIK 0001069530)
Date: Aug. 6, 2010 · CIK: 0001069530 · Accession: 0001193125-10-181526
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-164648
Letter
Acceleration Request
August 6, 2010
Via EDGAR and Facsimile
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3561
Attn: Jeffrey P. Riedler, Assistant Director
Karen Ubell
Re: Pain Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-164648
Acceleration Request
Requested Date: August 10, 2010
Requested Time: 5:00 p.m. Eastern Daylight Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pain Therapeutics, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-164648) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the Securities and Exchange Commission (the “Commission”).
In connection with the acceleration request, the Company hereby acknowledges that:
•
should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
•
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
•
the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
U.S. Securities and Exchange Commission
Re: Pain Therapeutics, Inc.
August 6, 2010
Page 2
We request that we be notified of the effectiveness of the Registration Statement by telephone to Gavin McCraley, of Wilson Sonsini Goodrich & Rosati, Professional Corporation, at (650) 565-3854. Please also provide a copy of the Commission’s order declaring the Registration Statement effective to Gavin McCraley via facsimile at (650) 493-6811 and via email at gmccraley@wsgr.com.
Sincerely,
PAIN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request August 6, 2010 Via EDGAR and Facsimile U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-3561 Attn: Jeffrey P. Riedler, Assistant Director Karen Ubell Re: Pain Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-164648 Acceleration Request Requested Date: August 10, 2010 Requested Time: 5:00 p.m. Eastern Daylight Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pain Therapeutics, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-164648) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the Securities and Exchange Commission (the “Commission”). In connection with the acceleration request, the Company hereby acknowledges that: • should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; • the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and • the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. U.S. Securities and Exchange Commission Re: Pain Therapeutics, Inc. August 6, 2010 Page 2 We request that we be notified of the effectiveness of the Registration Statement by telephone to Gavin McCraley, of Wilson Sonsini Goodrich & Rosati, Professional Corporation, at (650) 565-3854. Please also provide a copy of the Commission’s order declaring the Registration Statement effective to Gavin McCraley via facsimile at (650) 493-6811 and via email at gmccraley@wsgr.com. Sincerely, PAIN THERAPEUTICS, INC. By: /s/ Peter S. Roddy Peter S. Roddy Vice President and Chief Financial Officer cc: Remi Barbier, President, Chief Executive Officer and Chairman of the Board of Directors Michael J. O’Donnell Gavin McCraley